Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2. (Q54375191)
scientific article published in October 1988
Language:
Current Data About Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2.
(P31) (Q13442814)
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

(P304) 457-472
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

(P433) 5
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

(P478) 7
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

(P577) Saturday, October 1, 1988
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

(P921) (Q5452194)

(P1433) (Q27711629)
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

(P1476) "Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2." (language: en)
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

(P2093) Kolitz JE
(P1545) 1
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

Wong GY
(P1545) 2
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

Welte K
(P1545) 3
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

Merluzzi VJ
(P1545) 4
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

Engert A
(P1545) 5
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

Bialas T
(P1545) 6
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

Polivka A
(P1545) 7
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

Bradley EC
(P1545) 8
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

Konrad M
(P1545) 9
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

Gnecco C
(P1545) 10
(P248)
(P698) 3263471
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3263471

other details
description scientific article published in October 1988

External Links
(P698) 3263471